Patentability of pharmaceuticals

Exploring the intersection of intellectual property rights (IPRs) and health, this book delves into whether IPRs can be considered human rights and their impact on access to medicines. It highlights a landmark case in South Africa that facilitated affordable treatment and discusses competition law as a potential solution. The text analyzes TRIPS provisions and includes case studies, emphasizing how human rights advocacy can enhance access to essential medicines. Future recommendations focus on the role of international organizations in addressing these challenges and reducing reliance on other nations.